References
Abbas AK,
Benoist C,
Bluestone JA et al.
(2013)
Regulatory T cells: recommendations to simplify the nomenclature.
Nature Immunology
14(4):
307–308.
Allam JP and
Novak N
(2011)
Local immunological mechanisms of sublingual immunotherapy.
Current Opinion in Allergy and Clinical Immunology
11(6):
571–578.
Anderson G,
Lane PJ and
Jenkinson EJ
(2007)
Generating intrathymic microenvironments to establish T‐cell tolerance.
Nature Reviews Immunology
7(12):
954–963.
Anolik JH,
Barnard J,
Owen T et al.
(2007)
Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.
Arthritis and Rheumatism
56(9):
3044–3056.
Barnes MJ and
Powrie F
(2009)
Regulatory T cells reinforce intestinal homeostasis.
Immunity
31(3):
401–411.
Billingham RE,
Brent L and
Medawar PB
(1953)
Actively acquired tolerance to foreign cells.
Nature
172:
603–606.
Bloom B,
Salgame P and
Diamond B
(1992)
Revisiting and revising suppressor T cells.
Immunology Today
13:
131–136.
Burnet M
(1959)
The Clonal Selection Theory of Acquired Immunity.
Nashville, TN: Vanderbilt University Press.
Campbell DJ and
Ziegler SF
(2007)
FOXP3 modifies the phenotypic and functional properties of regulatory T cells.
Nature Reviews Immunology
7(4):
305–310.
Carosella ED,
Gregori S and
LeMaoult J
(2011)
The tolerogenic interplay(s) among HLA‐G, myeloid APCs, and regulatory cells.
Blood
118(25):
6499–6505.
Chappert P and
Schwartz RH
(2010)
Induction of T cell anergy: integration of environmental cues and infectious tolerance.
Current Opinion in Immunology
22(5):
552–559.
Chase M
(1946)
Inhibition of experimental drug allergy by prior feeding of the sensitizing agent.
Proceedings of the Society for Experimental Biology and Medicine
61:
257–259.
Chaudhry A,
Rudra D,
Treuting P et al.
(2009)
CD4+ regulatory T cells control TH17 responses in a Stat3‐dependent manner.
Science
326(5955):
986–991.
Chen C,
Nagy Z,
Radic MZ et al.
(1995)
The site and stage of anti‐DNA B‐cell deletion.
Nature
373(6511):
252–255.
DiLillo DJ,
Matsushita T and
Tedder TF
(2010)
B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer.
Annals of the New York Academy of Sciences
1183:
38–57.
Duddy M,
Niino M,
Adatia F et al.
(2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.
Journal of Immunology
178(10):
6092–6099.
Fridman WH,
Mlecnik B,
Bindea G,
Pages F and
Galon J
(2011)
Immunosurveillance in human non‐viral cancers.
Current Opinion in Immunology
23(2):
272–278.
Gay D,
Saunders T,
Camper S and
Weigert M
(1993)
Receptor editing: an approach by autoreactive B cells to escape tolerance.
Journal of Experimental Medicine
177(4):
999–1008.
Glocker EO,
Kotlarz D,
Boztug K et al.
(2009)
Inflammatory bowel disease and mutations affecting the interleukin‐10 receptor.
New England Journal of Medicine
361(21):
2033–2045.
Goodnow CC,
Crosbie J,
Adelstein S et al.
(1988)
Altered immunoglobulin expression and functional silencing of self‐reactive B lymphocytes in transgenic mice.
Nature
334(6184):
676–682.
Griffith TS and
Ferguson TA
(2011)
Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells.
Immunity
35(4):
456–466.
Healy JI,
Dolmetsch RE,
Timmerman LA et al.
(1997)
Different nuclear signals are activated by the B cell receptor during positive versus negative signaling.
Immunity
6(4):
419–428.
Hikada M and
Zouali M
(2010)
Multistoried roles for B lymphocytes in autoimmunity.
Nature Immunology
11(12):
1065–1068.
Hoehlig K,
Shen P,
Lampropoulou V et al.
(2012)
Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE.
European Journal of Immunology
42(5):
1164–1173.
Huehn J,
Polansky JK and
Hamann A
(2009)
Epigenetic control of FOXP3 expression: the key to a stable regulatory T‐cell lineage?
Nature Reviews Immunology
9(2):
83–89.
Iwata Y,
Matsushita T,
Horikawa M et al.
(2011)
Characterization of a rare IL‐10‐competent B‐cell subset in humans that parallels mouse regulatory B10 cells.
Blood
117(2):
530–541.
Jerne N
(1984)
Idiotypic networks and other preconceived ideas.
Immunological Reviews
79:
5–24.
Kamada N and
Nunez G
(2013)
Role of the gut microbiota in the development and function of lymphoid cells.
Journal of Immunology
190(4):
1389–1395.
Koch MA,
Tucker‐Heard G,
Perdue NR et al.
(2009)
The transcription factor T‐bet controls regulatory T cell homeostasis and function during type 1 inflammation.
Nature Immunology
10(6):
595–602.
Li L,
Iwamoto Y,
Berezovskaya A and
Boussiotis VA
(2006)
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
Nature Immunology
7(11):
1157–1165.
Lynch RJ and
Platt JL
(2009)
Escaping from rejection.
Transplantation
88(11):
1233–1236.
Matsushita T,
Horikawa M,
Iwata Y and
Tedder TF
(2010)
Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late‐phase immunopathogenesis.
Journal of Immunology
185(4):
2240–2252.
Matzinger P
(2007)
Friendly and dangerous signals: is the tissue in control?
Nature Immunology
8(1):
11–13.
Mauri C and
Bosma A
(2012)
Immune regulatory function of B cells.
Annual Reviews of Immunology
30:
221–241.
Mills KH
(2012)
TLR‐dependent T cell activation in autoimmunity.
Nature Reviews Immunology
11(12):
807–822.
Mosmann TR,
Cherwinski H,
Bond MW,
Giedlin MA and
Coffman RL
(1986)
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
Journal of Immunology
136:
2348–2357.
Nemazee DA and
Bürki K
(1989)
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti‐MHC class I antibody genes.
Nature
337:
562–566.
Nossal GJ and
Pike BL
(1980)
Clonal anergy: persistence in tolerant mice of antigen‐binding B lymphocytes incapable of responding to antigen or mitogen.
Proceedings of the National Academy of Sciences of the USA
77:
1602–1606.
Olenchock BA,
Guo R,
Carpenter JH et al.
(2006)
Disruption of diacylglycerol metabolism impairs the induction of T cell anergy.
Nature Immunology
7(11):
1174–1181.
Owen RD
(1945)
Immunogenetic consequences of vascular anastomoses between bovine twins.
Science
102:
400–401.
Radic MZ and
Zouali M
(1996)
Receptor editing, immune diversification, and self‐tolerance.
Immunity
5(6):
505–511.
Sakaguchi S
(2000)
Regulatory T cells: key controllers of immunologic self‐tolerance.
Cell
101(5):
455–458.
Shen P,
Roch T,
Lampropoulou V et al.
(2014)
IL‐35‐producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Nature
507(7492):
366–370.
Shevach EM
(2009)
Mechanisms of foxp3+ T regulatory cell‐mediated suppression.
Immunity
30(5):
636–645.
Spitaler M,
Emslie E,
Wood CD and
Cantrell D
(2006)
Diacylglycerol and protein kinase D localization during T lymphocyte activation.
Immunity
24(5):
535–546.
Tiegs SL,
Russell DM and
Nemazee D
(1993)
Receptor editing in self‐reactive bone marrow B cells.
Journal of Experimental Medicine
177(4):
1009–1020.
Van Parijs L and
Abbas A
(1998)
Homeostasis and self‐tolerance in the immune system: turning lymphocyte off.
Science
280:
243–248.
Weiner HL,
da Cunha AP,
Quintana F and
Wu H
(2011)
Oral tolerance.
Immunological Reviews
241(1):
241–259.
Yoshizaki A,
Miyagaki T,
DiLillo DJ et al.
(2012)
Regulatory B cells control T‐cell autoimmunity through IL‐21‐dependent cognate interactions.
Nature
491(7423):
264–268.
Zha Y,
Marks R,
Ho AW et al.
(2006)
T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase‐alpha.
Nature Immunology
7(11):
1166–1173.
Zheng Y,
Chaudhry A,
Kas A et al.
(2009)
Regulatory T‐cell suppressor program co‐opts transcription factor IRF4 to control T(H)2 responses.
Nature
458(7236):
351–356.
Zouali M (ed.)
(2005)
Molecular Autoimmunity.
New York, NY: Springer.
Zouali M
(2008)
Receptor editing and receptor revision in rheumatic autoimmune diseases.
Trends in Immunology
29(3):
103–109.
Zouali M,
Isenberg D and
Morrow JWW
(1996)
Idiotype network manipulation for autoimmune diseases: where are we going.
Autoimmunity
24:
55–63.
Further Reading
Chappert P and
Schwartz RH
(2010)
Induction of T cell anergy: integration of environmental cues and infectious tolerance.
Current Opinion in Immunology
22(5):
552–559.
Griffith TS and
Ferguson TA
(2011)
Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells.
Immunity
35(4):
456–466.
Healy J and
Goodnow C
(1998)
Positive versus negative signaling by lymphocyte antigen receptors.
Annual Review of Immunology
16:
645–670.
Kappler JW,
Roehm N and
Marrack P
(1987)
T cell tolerance by clonal elimination in the thymus.
Cell
49:
273–280.
Paul WE
(2012)
Fundamental Immunology,
7th edn.
New York, NY: Lippincott Williams & Wilkins.
Zouali M (ed.)
(2009)
The Epigenetics of Autoimmune Diseases.
Hoboken, New Jersey, USA: Wiley‐Blackwell.
(an imprint of John Wiley & Sons Ltd).
Zouali M
(2013)
The epigenetic landscape of B lymphocyte tolerance to self.
FEBS Letters
587(13):
2067–2073.
Zouali M
(2014)
Tweaking the B lymphocyte compartment in autoimmune diseases.
Nature Immunology
15(3):
209–212.